Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
| ERICKSON AIR | EAC | 5.10% |
| ASSURED GUAR | AGO | 4.98% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Large-cap oilfield services company National Oilwell Varco Inc. (NOV - Analyst Report) has agreed to acquire smaller rival Robbins & Myers Inc. (RBN) for about $2.5 billion in cash.
The transaction has been approved by the boards of both Houston-based companies but awaits regulatory and shareholder approval. In particular, the deal needs the go-ahead of at least two-thirds of Robbins & Myers shareholders. We expect the buyout to conclude during the fourth quarter of 2012.
M.H.M. & Company – Robbins & Myers’ largest shareholder that controls about 10% of the shares – have agreed to vote in favor of the transaction.
As per the deal, Robbins & Myers shareholders would get $60 in cash for each share they hold. At Robbins & Myers’ Wednesday closing stock price of $46.80 on the New York Stock Exchange, the deal values the company’s shares at a 28% premium.
Robbins & Myers specializes in the manufacture of critical well drilling equipment parts – including valve controls and grinders – to manage the flow of oil and gas in drilling operations.
The acquisition – National Oilwell Varco’s largest in more than four years – will allow the energy equipment contractor to broaden scale and scope of the solutions that it offers to oil and gas customers worldwide. Post merger, National Oilwell Varco expects Robbins & Myers’ complementary products to benefit its product line of well tools, pumps and valves.
In particular, the move will help National Oilwell Varco to strengthen its position as a supplier of blowout preventer (a critical safety machine that can shut a well off in case of an emergency), as Robbins & Myers is the fourth-largest maker of such devices.
National Oilwell Varco, which ranks ahead of Cameron International Corp. (CAM - Analyst Report) as the biggest U.S. maker of oilfield equipment, is currently a Zacks #3 Rank (Hold) stock, implying that it is expected to perform in line with the broader U.S. equity market over the next one to three months. We are also maintaining our long-term Neutral recommendation on the stock.
Get the full Analyst Report on NOV - FREE
Get the full Analyst Report on CAM - FREE